Peripheral neuropathy — all decisions

The Board granted a 100 percent rating for PTSD and depressive disorder with insomnia from December 29, 2020, but denied increased ratings for the veteran's other conditions.

The appeal was dismissed due to the Veteran's death during its pendency.

The Board denied service connection for chronic fatigue syndrome but granted service connection for systemic joint pain, muscle pain, fever, and neuropathy, secondary to the Veteran's service-connected chronic urticaria.

The Board granted service connection for left and right lower extremity peripheral neuropathy, to include as due to herbicide exposure, but denied an initial compensable evaluation for hypothyroidism.

The appeal for service connection for an anxiety disorder was dismissed, and the appeals for service connection for Parkinson's disease, a respiratory condition (COPD), a heart disability (coronary artery disease), rhinitis, diabetes mellitus, type II (diabetes), right lower extremity diabetic peripheral neuropathy, left lower extremity diabetic peripheral neuropathy, and right upper extremity diabetic peripheral neuropathy were remanded for further development.

The Board remands the Veteran's claims for a higher disability rating for left and right lower sciatic peripheral neuropathy due to an incomplete evaluation of the severity of his condition without considering medication effects.

The Veteran withdrew his appeals for service connection for skeletal arthritis, a bilateral eye disorder, and peripheral neuropathy in both upper extremities.

The Board denied an initial increased rating in excess of 10 percent for both left and right lower extremity diabetic peripheral neuropathy as the evidence did not support moderate incomplete paralysis of the sciatic nerve group.

The Board remands the claims for further development, including additional examinations to address the impact of medication on the Veteran's neuropathy and to determine the nature and etiology of his GERD.

The Board denied higher ratings for the Veteran's left and right lower extremity radiculopathy with diabetic peripheral neuropathy, but granted separate 20 percent ratings from October 28, 2024, for left and right lower extremity radiculopathy affecting the femoral nerve. The Board also denied higher ratings for the Veteran's left and right upper extremity peripheral neuropathy.

The Board remands the claims for an earlier effective date and to obtain medical opinions on whether the Veteran's sleep apnea is secondary to his sarcoidosis, and whether his peripheral neuropathy of the bilateral upper and lower extremities are due to his service-connected sarcoidosis.

The Board granted an effective date of April 26, 2018, for the award of service connection for multiple sclerosis and associated conditions, chronic migraine headaches, and trigeminal neuralgia.

The Veteran is granted SMC benefits based on the loss of use of both feet and hands, as well as other conditions entitling him to additional SMC.

The Board denied service connection for diabetes mellitus type II and remanded the claim for further development regarding neuropathy of the left lower extremity.

The Board denied an increased rating for lumbosacral strain but granted separate ratings of 10 percent each for right and left lower extremity neuropathy of the anterior tibial nerve.

The Board granted service connection for lumbar disorders (strain and spondylosis) and bilateral lower extremity peripheral neuropathy, finding that the evidence is nearly equal that these conditions are related to the Veteran's active-duty service.

The Board granted service connection for diabetic retinopathy, peripheral neuropathy of the upper extremities, kidney condition, obstructive sleep apnea, asthma, and tinnitus.

The Board granted service connection for ischemic optic neuropathy as secondary to the Veteran's service-connected carcinoma of glottis and laryngeal cancer, but denied service connection for tooth decay.

The Board granted service connection for lumbar spine degenerative disc disease and coronary artery disease associated with herbicide agent exposure. Bilateral hearing loss was denied.

The Board denied service connection for diabetes mellitus, type II and related conditions due to a lack of evidence linking the Veteran's current disabilities to his active service or toxic exposure at Camp Lejeune.